Rl. Brackett et al., Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex, NEUROPHARM, 39(3), 2000, pp. 407-418
N-methyl-D-aspartate (NMDA) receptors appear to be involved in the behavior
al toxic effects of cocaine. Therefore, different classes of NMDA receptor
antagonists were compared for their ability to attenuate cocaine-induced co
nvulsions and lethality in male, Swiss Webster mice. The mice were pre-trea
ted (i.p.) with vehicle or an antagonist from one of the following classes:
NMDA/glycine site antagonist (7-chlorokynurenic acid, ACEA-1021, ACEA-1031
, ACEA-1328, DCQX, R(+)-HA-966), competitive antagonist (CPP, D-AP7), chann
el blocker (MK-801, memantine), or allosteric modulator (ifenprodil, CP-101
,606, Co 101022, haloperidol). After a 15 min pre-treatment period, the mic
e were administered a convulsive (60 mg/kg, i.p.) or lethal (125 mg/kg, i.p
.) dose of cocaine, equivalent to the calculated ED/LD97 values. Pre-treatm
ent with competitive or NMDA/glycine site antagonists dose-dependently atte
nuated cocaine-induced convulsions and lethality (P < 0.05). Pre-treatment
with channel blockers or allosteric modulators of the NMDA receptor protect
ed against cocaine-induced convulsions (P < 0.05), but were ineffective or
less effective than the competitive and glycine site antagonists in prevent
ing death. The glutamate release inhibitor riluzole failed to prevent both
the convulsions and lethality induced by cocaine. Significantly, post-treat
ment with NMDA/glycine site antagonists (ACEA-1021, ACEA-1031, ACEA-1328) a
fter a cocaine overdose prevented death in a significant number of animals.
The data suggest that NMDA receptors are involved in the pathophysiology o
f a cocaine overdose. (C) 2000 Elsevier Science Ltd. All rights reserved.